Genmab A/S (GMAB)
USD 19.32
(2.71%)
USD 19.32
(2.71%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 770 Million DKK | 28.98% |
| 2022 | 597 Million DKK | 40.47% |
| 2021 | 425 Million DKK | 33.23% |
| 2020 | 319 Million DKK | 76.24% |
| 2019 | 181 Million DKK | 0.0% |
| 2018 | - DKK | 0.0% |
| 2017 | - DKK | 0.0% |
| 2016 | - DKK | -100.0% |
| 2015 | 118 Thousand DKK | -66.76% |
| 2014 | 355 Thousand DKK | -85.71% |
| 2013 | 2.48 Million DKK | -56.1% |
| 2012 | 5.66 Million DKK | -52.22% |
| 2011 | 11.84 Million DKK | -91.14% |
| 2010 | 133.71 Million DKK | 436.11% |
| 2009 | 24.94 Million DKK | 69.69% |
| 2008 | 14.69 Million DKK | -6.18% |
| 2007 | 15.66 Million DKK | -13.95% |
| 2006 | 18.2 Million DKK | -20.97% |
| 2005 | 23.03 Million DKK | -20.58% |
| 2004 | 29 Million DKK | 20.16% |
| 2003 | 24.13 Million DKK | 75.22% |
| 2002 | 13.77 Million DKK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.01 Billion DKK | 31.17% |
| 2024 Q2 | 1.01 Billion DKK | 0.89% |
| 2023 Q2 | 803 Million DKK | -3.14% |
| 2023 Q4 | 770 Million DKK | -2.9% |
| 2023 FY | 770 Million DKK | 28.98% |
| 2023 Q3 | 793 Million DKK | -1.25% |
| 2023 Q1 | 829 Million USD | 38.86% |
| 2022 Q4 | 597 Million DKK | -5.09% |
| 2022 Q1 | 416 Million DKK | -2.12% |
| 2022 FY | 597 Million DKK | 40.47% |
| 2022 Q2 | 634 Million DKK | 52.4% |
| 2022 Q3 | 629 Million DKK | -0.79% |
| 2021 Q3 | 437 Million DKK | -1.35% |
| 2021 FY | 425 Million DKK | 33.23% |
| 2021 Q2 | 443 Million DKK | 17.2% |
| 2021 Q1 | 378 Million DKK | 18.5% |
| 2021 Q4 | 425 Million DKK | -2.75% |
| 2020 Q1 | 174 Million DKK | -3.87% |
| 2020 Q4 | 319 Million DKK | -5.34% |
| 2020 Q3 | 337 Million DKK | -5.34% |
| 2020 Q2 | 356 Million DKK | 104.6% |
| 2020 FY | 319 Million DKK | 76.24% |
| 2019 FY | 181 Million DKK | 0.0% |
| 2019 Q1 | 199.42 Million DKK | 0.0% |
| 2019 Q2 | 194.04 Million DKK | -2.7% |
| 2019 Q3 | 188.61 Million DKK | -2.8% |
| 2019 Q4 | 181 Million DKK | -4.04% |
| 2018 Q2 | - DKK | 0.0% |
| 2018 FY | - DKK | 0.0% |
| 2018 Q1 | - DKK | 0.0% |
| 2018 Q4 | - DKK | 0.0% |
| 2018 Q3 | - DKK | 0.0% |
| 2017 Q3 | - DKK | 0.0% |
| 2017 FY | - DKK | 0.0% |
| 2017 Q2 | - DKK | 0.0% |
| 2017 Q1 | - DKK | 0.0% |
| 2017 Q4 | - DKK | 0.0% |
| 2016 Q1 | 59 Thousand DKK | -50.0% |
| 2016 Q4 | - DKK | 0.0% |
| 2016 Q3 | - DKK | 0.0% |
| 2016 Q2 | - DKK | -100.0% |
| 2016 FY | - DKK | -100.0% |
| 2015 FY | 118 Thousand DKK | -66.76% |
| 2015 Q4 | 118 Thousand DKK | -33.71% |
| 2015 Q3 | 178 Thousand DKK | -24.89% |
| 2015 Q2 | 237 Thousand DKK | -19.93% |
| 2015 Q1 | 296 Thousand DKK | -16.62% |
| 2014 Q3 | 415 Thousand DKK | -12.45% |
| 2014 Q4 | 355 Thousand DKK | -14.46% |
| 2014 FY | 355 Thousand DKK | -85.71% |
| 2014 Q1 | 535 Thousand DKK | -78.47% |
| 2014 Q2 | 474 Thousand DKK | -11.4% |
| 2013 Q1 | 4.73 Million DKK | -16.4% |
| 2013 FY | 2.48 Million DKK | -56.1% |
| 2013 Q4 | 2.48 Million DKK | -98.41% |
| 2013 Q3 | 156.7 Million DKK | 3376.95% |
| 2013 Q2 | 4.5 Million DKK | -4.75% |
| 2012 Q1 | 10.3 Million DKK | -12.98% |
| 2012 FY | 5.66 Million DKK | -52.22% |
| 2012 Q3 | 7.38 Million DKK | -15.13% |
| 2012 Q4 | 5.66 Million DKK | -23.39% |
| 2012 Q2 | 8.7 Million DKK | -15.54% |
| 2011 Q1 | 16.4 Million DKK | -87.73% |
| 2011 Q2 | 14.9 Million DKK | -9.16% |
| 2011 Q3 | 13.38 Million DKK | -10.2% |
| 2011 FY | 11.84 Million DKK | -91.14% |
| 2011 Q4 | 11.84 Million DKK | -11.49% |
| 2010 Q1 | 23.05 Million DKK | -7.56% |
| 2010 Q4 | 133.71 Million DKK | 580.46% |
| 2010 FY | 133.71 Million DKK | 436.11% |
| 2010 Q3 | 19.65 Million DKK | -7.94% |
| 2010 Q2 | 21.34 Million DKK | -7.42% |
| 2009 FY | 24.94 Million DKK | 69.69% |
| 2009 Q4 | 24.94 Million DKK | 0.0% |
| 2008 FY | 14.69 Million DKK | -6.18% |
| 2007 FY | 15.66 Million DKK | -13.95% |
| 2006 FY | 18.2 Million DKK | -20.97% |
| 2005 FY | 23.03 Million DKK | -20.58% |
| 2004 FY | 29 Million DKK | 20.16% |
| 2003 FY | 24.13 Million DKK | 75.22% |
| 2002 FY | 13.77 Million DKK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | -119.845% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -5230.933% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -2701.528% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -557.036% |
| MiMedx Group, Inc. | 48.09 Million USD | -1500.865% |
| Novavax, Inc. | 280.63 Million USD | -174.378% |
| Seer, Inc. | 28.25 Million USD | -2624.796% |
| Acelyrin, Inc. | 1.19 Million USD | -64389.112% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -235.964% |
| IO Biotech, Inc. | 2.49 Million USD | -30774.098% |
| Ardelyx, Inc. | 55.98 Million USD | -1275.442% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -984.874% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -3586.992% |
| Fortress Biotech, Inc. | 88.59 Million USD | -769.153% |
| Fortress Biotech, Inc. | 88.59 Million USD | -769.153% |
| Geron Corporation | 85.89 Million USD | -796.402% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -568.571% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -11639.594% |
| Incyte Corporation | 38.28 Million USD | -1911.126% |
| Innoviva, Inc. | 449.07 Million USD | -71.463% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -23397.101% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -12389.862% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 6.6 Million USD | -11557.835% |
| Onconetix, Inc. | 9.88 Million USD | -7688.972% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -242038.365% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -95149.641% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -26710.585% |
| Vaxcyte, Inc. | 29.22 Million USD | -2534.821% |
| Precigen, Inc. | 7.09 Million USD | -10749.655% |
| Pharming Group N.V. | 171.54 Million USD | -348.862% |
| ContextLogic Inc. | 6 Million USD | -12733.333% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -79445.455% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -3509.77% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -1171.068% |
| AlloVir, Inc. | 27.42 Million USD | -2707.248% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -597.729% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -265744.505% |
| Summit Therapeutics Inc. | 106.09 Million USD | -625.737% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -46994.801% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -12303.351% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1944.284% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -659.489% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -1028.536% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -9955.636% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -2065.643% |
| Chimerix, Inc. | 2.14 Million USD | -35814.179% |
| PDS Biotechnology Corporation | 23.85 Million USD | -3128.293% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -4475.163% |
| CRISPR Therapeutics AG | 238.63 Million USD | -222.673% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -2297.41% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -453.837% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -2597.873% |
| Precision BioSciences, Inc. | 31.26 Million USD | -2362.582% |
| Dyadic International, Inc. | 136.92 Thousand USD | -562235.225% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2454.999% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -14015.49% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -639.091% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 71.297% |
| Aptorum Group Limited | 3.36 Million USD | -22800.33% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1612.786% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -762276.238% |
| Clearside Biomedical, Inc. | 43 Million USD | -1690.656% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -123693.615% |
| GT Biopharma, Inc. | 58 Thousand USD | -1327486.207% |
| Alkermes plc | 290.73 Million USD | -164.851% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1591.936% |
| Jaguar Health, Inc. | 35.86 Million USD | -2047.239% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -36220.755% |
| AbCellera Biologics Inc. | 77.38 Million USD | -895.089% |
| PureTech Health plc | 25.51 Million USD | -2918.188% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -170794.265% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1920.785% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -84888.962% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -5834.033% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -10862.415% |
| AnaptysBio, Inc. | 17.81 Million USD | -4222.443% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -3859.887% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -958469.864% |
| Molecular Templates, Inc. | 12.23 Million USD | -6195.993% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -472.474% |
| Vaxxinity, Inc. | 15.16 Million USD | -4976.477% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -2912.991% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -46481.972% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -3037.479% |
| Structure Therapeutics Inc. | 5.45 Million USD | -14020.665% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -162005.263% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -11165.545% |
| ImmuCell Corporation | 11.96 Million USD | -6333.123% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -328298.821% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -359713.084% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | -283.793% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -7715.672% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -1140.435% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -643.703% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -266.421% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -21547.456% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -45543.154% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -255957.25% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -2974.834% |
| Aptose Biosciences Inc. | 1 Million USD | -76152.27% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -8895463.771% |
| Soligenix, Inc. | 3.49 Million USD | -21934.241% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1498.472% |
| Kura Oncology, Inc. | 17.2 Million USD | -4376.744% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -733.036% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -487241.772% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -35713.953% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -5410.233% |
| Autolus Therapeutics plc | 52.96 Million USD | -1353.735% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -13979.356% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1740.212% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -235.611% |
| GRI Bio, Inc. | 14 Thousand USD | -5499900.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -6097.682% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1800.953% |
| INmune Bio, Inc. | 10.43 Million USD | -7277.599% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -328.664% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -12935.252% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -942603.232% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -93025.184% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1387.204% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1221.185% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1230.523% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -60.136% |
| Verastem, Inc. | 41.55 Million USD | -1752.877% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -14159.259% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -6671.017% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -7746.734% |
| Histogen Inc. | 4.62 Million USD | -16559.455% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -22687.807% |
| Organovo Holdings, Inc. | 1.39 Million USD | -55136.729% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -1573.85% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -14724.798% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -3525.406% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -3606457.377% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -810.295% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -368285.8% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -2448.319% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -474280.379% |
| Apollomics, Inc. | 4.66 Million USD | -16420.06% |
| Amarin Corporation plc | 8.73 Million USD | -8713.094% |
| Mesoblast Limited | 118.92 Million USD | -547.478% |
| Turnstone Biologics Corp. | 3.21 Million USD | -23857.685% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -809.37% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -311640.891% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -688.878% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -305.383% |
| Better Therapeutics, Inc. | 14.88 Million USD | -5074.731% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -2415.189% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -594.144% |
| NLS Pharmaceutics AG | 1.63 Million USD | -47030.949% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -12461.175% |
| Gritstone bio, Inc. | 104.77 Million USD | -634.908% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -27538.191% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1575508.758% |
| Avid Bioservices, Inc. | 207.83 Million USD | -270.488% |
| Insmed Incorporated | 1.2 Billion USD | 36.046% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -11373.7% |
| OmniAb, Inc. | 25.56 Million USD | -2912.402% |
| Alector, Inc. | 38.91 Million USD | -1878.519% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -259.921% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -4982.173% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -60.942% |
| Aura Biosciences, Inc. | 19.55 Million USD | -3837.209% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -1118.991% |
| Immunic, Inc. | 1.33 Million USD | -57621.139% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -2326.573% |
| Veracyte, Inc. | 12.63 Million USD | -5996.595% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -19.405% |
| FibroGen, Inc. | 170.45 Million USD | -351.732% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -8379.242% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -377515.725% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 86.716% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -2080981.081% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -18073.236% |
| TG Therapeutics, Inc. | 110.79 Million USD | -594.977% |
| Galecto, Inc. | 249 Thousand USD | -309136.948% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -46118.487% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 54.112% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -10423.439% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -14167.185% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -27538.191% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -2764.477% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1608.34% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -54163.566% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1602.184% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1683.687% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1496.55% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 9.274% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -74846.613% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -6928.754% |
| NexImmune, Inc. | 68.8 Thousand USD | -1118939.661% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -5424727.392% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 71.512% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -196327.569% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -11049.725% |
| Ainos, Inc. | 5.96 Million USD | -12811.759% |
| Pluri Inc. | 29.61 Million USD | -2500.297% |
| Prothena Corporation plc | 11.83 Million USD | -6406.126% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -2951.318% |
| Celularity Inc. | 65.41 Million USD | -1077.064% |
| Rallybio Corporation | 392 Thousand USD | -196328.571% |
| Cue Biopharma, Inc. | 14.69 Million USD | -5139.878% |
| MeiraGTx Holdings plc | 89.26 Million USD | -762.61% |
| Omeros Corporation | 338.28 Million USD | -127.621% |
| Humacyte, Inc. | 58.1 Million USD | -1225.164% |
| Immunocore Holdings plc | 84.03 Million USD | -816.318% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -41454.236% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -15688.395% |
| Blueprint Medicines Corporation | 774.12 Million USD | 0.532% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -15244.759% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -1145.592% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -639.702% |
| Pulmatrix, Inc. | 8.75 Million USD | -8693.97% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -11031.994% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -5459.567% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -567.557% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -2340.725% |
| Cytokinetics, Incorporated | 755.77 Million USD | -1.883% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -5653.138% |
| Nutriband Inc. | 241.28 Thousand USD | -319024.687% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -13984.507% |
| Vor Biopharma Inc. | 35.66 Million USD | -2059.282% |
| Roivant Sciences Ltd. | 499.74 Million USD | -54.077% |
| Evogene Ltd. | 1.13 Million USD | -67562.566% |
| ProKidney Corp. | 4.41 Million USD | -17348.448% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -62705.873% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1395712.562% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 55.743% |
| CorMedix Inc. | 667.63 Thousand USD | -115232.998% |
| BioLineRx Ltd. | 11.59 Million USD | -6543.085% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1878.417% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -972.319% |
| Atai Life Sciences N.V. | 16.47 Million USD | -4573.464% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -31315.8% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -113974.074% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1582.214% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -1184515.385% |
| MediciNova, Inc. | 215.92 Thousand USD | -356503.651% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -30761.723% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -60961.293% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -313.152% |
| Biomea Fusion, Inc. | 10.29 Million USD | -7378.632% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -85.531% |
| Mereo BioPharma Group plc | 5.95 Million USD | -12836.828% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -21348.468% |
| Absci Corporation | 15.95 Million USD | -4725.468% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -8305.196% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -5148.449% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -2708.681% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -6181.612% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -6057.045% |
| Allakos Inc. | 41.46 Million USD | -1756.988% |
| Imunon, Inc. | 1.62 Million USD | -47292.957% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -7015.793% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -509833.775% |
| BioAtla, Inc. | 2.46 Million USD | -31200.813% |
| NLS Pharmaceutics AG | 1.63 Million USD | -47030.949% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -681315.929% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -709.495% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -13783.88% |
| XOMA Corporation | 124.45 Million USD | -518.722% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -3966.973% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1683.77% |
| aTyr Pharma, Inc. | 15.09 Million USD | -5001.027% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -6813.27% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -2856.649% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -3558.305% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -220530.372% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -235739.666% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -47089.324% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 48.641% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -469506.689% |
| UroGen Pharma Ltd. | 100.21 Million USD | -668.356% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -321.343% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -222223.599% |
| Orgenesis Inc. | 22.62 Million USD | -3303.917% |
| Entera Bio Ltd. | 390 Thousand USD | -197335.897% |
| GH Research PLC | 343 Thousand USD | -224389.796% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -252359.016% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -79036.691% |
| Xencor, Inc. | 83.43 Million USD | -822.885% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -445829.589% |
| Replimune Group, Inc. | 75.86 Million USD | -914.907% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -62796.883% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -8088.005% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -469506.689% |
| Portage Biotech Inc. | 47 Thousand USD | -1638197.872% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -60961.293% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -31757.675% |
| OncoCyte Corporation | 2.86 Million USD | -26738.62% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -59166.511% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -511344.399% |
| Purple Biotech Ltd. | 351 Thousand USD | -219273.219% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -24274.802% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1812.141% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -1404.112% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -542153.521% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -14619.939% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -2779.797% |
| Curis, Inc. | 2.79 Million USD | -27459.055% |
| Daré Bioscience, Inc. | 5.31 Million USD | -14378.733% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -35941.113% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -136183.186% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -4502.235% |
| BeiGene, Ltd. | 930.18 Million USD | 17.221% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -4854.158% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -775.557% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -67384.663% |
| Erasca, Inc. | 55.85 Million USD | -1278.471% |
| bluebird bio, Inc. | 330.32 Million USD | -133.103% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 32.091% |
| DBV Technologies S.A. | 14.38 Million USD | -5254.287% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -30675.38% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -16480.534% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -90.225% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1572.495% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -16606.444% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -30191.109% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -3984.231% |
| MacroGenics, Inc. | 33.97 Million USD | -2166.639% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -3579.985% |
| Prime Medicine, Inc. | 13.63 Million USD | -5548.06% |
| Aditxt, Inc. | 18.21 Million USD | -4126.592% |
| Adagene Inc. | 22.3 Million USD | -3351.851% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -4931.693% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -26.03% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -3694.412% |
| SciSparc Ltd. | 76 Thousand USD | -1013057.895% |
| Vericel Corporation | 88.14 Million USD | -773.58% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -838.832% |
| Generation Bio Co. | 97.89 Million USD | -686.565% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -233942.553% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -2943.719% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -273.939% |
| Invivyd, Inc. | 2.16 Million USD | -35465.82% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1340.168% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -21851744.494% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -13791.395% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1222122.222% |
| 2seventy bio, Inc. | 256.67 Million USD | -199.993% |
| ADMA Biologics, Inc. | 141.41 Million USD | -444.485% |
| Clene Inc. | 32.16 Million USD | -2294.204% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -13620.222% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -34979.727% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1419.577% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -159901.662% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -298.567% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -2455.932% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -4377.525% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -518.275% |
| Evaxion Biotech A/S | 10.86 Million USD | -6983.926% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -823.383% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -927.941% |
| Trevena, Inc. | 35.23 Million USD | -2085.451% |
| Surrozen, Inc. | 3.37 Million USD | -22687.807% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -11753.448% |
| Cingulate Inc. | 3.13 Million USD | -24460.628% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1877948.78% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -2752.908% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -153622.377% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -127594.859% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1246.036% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -165491.398% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -2623.543% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -3708.299% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -49417.685% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -61011.111% |
| Statera Biopharma, Inc. | 16.26 Million USD | -4635.216% |
| ImmunityBio, Inc. | 883.67 Million USD | 12.864% |
| Korro Bio, Inc. | 33.2 Million USD | -2218.788% |
| Kineta, Inc. | 1.31 Million USD | -58366.211% |
| BioVie Inc. | 6.11 Million USD | -12499.307% |
| Codexis, Inc. | 22.36 Million USD | -3343.033% |
| Celularity Inc. | 65.41 Million USD | -1077.064% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1388.556% |
| Celcuity Inc. | 37.44 Million USD | -1956.279% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -343190.236% |
| Cibus, Inc. | 24.62 Million USD | -3027.412% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -200944.386% |
| IN8bio, Inc. | 4.89 Million USD | -15636.767% |
| Kodiak Sciences Inc. | 181.63 Million USD | -323.934% |
| Annexon, Inc. | 31.35 Million USD | -2355.749% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -926.174% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -32777.882% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -19628.414% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 47.026% |
| Eyenovia, Inc. | 16.1 Million USD | -4680.305% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -590.645% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -78072.589% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -6620.782% |
| Arcellx, Inc. | 97.62 Million USD | -688.732% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -35730.619% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -2804.236% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -24722.695% |
| Moolec Science SA | 2.64 Million USD | -29008.351% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -2602.987% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -12097.054% |
| Royalty Pharma plc | 6.13 Billion USD | 87.45% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -31956.619% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -667989.611% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -2176.086% |
| Humacyte, Inc. | 58.1 Million USD | -1225.164% |
| 89bio, Inc. | 27.1 Million USD | -2740.49% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -5695.574% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -30467.686% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -57448.58% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -625.977% |
| Notable Labs, Ltd. | 2.04 Million USD | -37479.307% |
| Liquidia Corporation | 3.5 Million USD | -21881.159% |
| Mustang Bio, Inc. | 2.49 Million USD | -30724.66% |
| Immunovant, Inc. | 138 Thousand USD | -557871.014% |
| Quantum-Si incorporated | 15.3 Million USD | -4931.693% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -8729.263% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -192400.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1333.678% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -942603.232% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -6962.276% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -365714.841% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -379210.345% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -3626.828% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -190966.998% |
| PepGen Inc. | 20.1 Million USD | -3730.084% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -134046.341% |
| United Therapeutics Corporation | 700 Million USD | -10.0% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -2831.658% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -17153.127% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -86807.449% |
| XOMA Corporation | 124.45 Million USD | -518.722% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -280921.898% |
| Bionomics Limited | 239.61 Million USD | -221.345% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -37756.459% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -5699.94% |
| uniQure N.V. | 138.4 Million USD | -456.322% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -801.397% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -74512.403% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -78072.589% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -8379.242% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -43975.558% |
| Altimmune, Inc. | 671 Thousand USD | -114654.098% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -73.011% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -5699.94% |
| Compugen Ltd. | 1.35 Million USD | -56894.819% |
| Peak Bio, Inc. | 10.72 Million USD | -7081.625% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1700.496% |
| Benitec Biopharma Inc. | 284 Thousand USD | -271026.761% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -810.65% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -3765.268% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -6437.057% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -741.917% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -3765.268% |
| Instil Bio, Inc. | 86.05 Million USD | -794.787% |
| argenx SE | 20 Million USD | -3750.0% |
| Immunome, Inc. | 1.65 Million USD | -46566.667% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -44331.621% |
| Verona Pharma plc | 51.32 Million USD | -1400.127% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -7774.821% |
| Shattuck Labs, Inc. | 4.2 Million USD | -18224.607% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -212607.182% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -18316.647% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -131523.932% |
| Moolec Science SA | 2.64 Million USD | -29008.351% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -2448.889% |
| Design Therapeutics, Inc. | 3.05 Million USD | -25145.902% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -293793.13% |
| NeurAxis, Inc. | 224.26 Thousand USD | -343251.467% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -5311.864% |
| Lumos Pharma, Inc. | 6.58 Million USD | -11593.242% |
| Achilles Therapeutics plc | 4.61 Million USD | -16584.724% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -7774.821% |
| 180 Life Sciences Corp. | 1.32 Million USD | -58230.284% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -4408.165% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -49417.685% |
| Nutriband Inc. | 241.28 Thousand USD | -319024.687% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -7439.411% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -93120.339% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -106.036% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -2458.225% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -20722.821% |
| Palisade Bio, Inc. | 369 Thousand USD | -208572.087% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -185442.169% |
| Beam Therapeutics Inc. | 173.17 Million USD | -344.642% |
| Neurogene Inc. | 16.25 Million USD | -4637.004% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -149.885% |
| AEON Biopharma, Inc. | 278 Thousand USD | -276878.417% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -229750.746% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -720259.993% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -915.001% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -1160.085% |
| Athira Pharma, Inc. | 1.58 Million USD | -48480.442% |
| Vaccinex, Inc. | 247 Thousand USD | -311640.891% |
| HCW Biologics Inc. | 6.45 Million USD | -11834.696% |
| XOMA Corporation | 124.45 Million USD | -518.722% |
| Nektar Therapeutics | 230.4 Million USD | -234.2% |
| Arvinas, Inc. | 3.4 Million USD | -22547.059% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -47089.324% |
| Merus N.V. | 12.16 Million USD | -6231.196% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -499.558% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -5474.055% |
| Rezolute, Inc. | 2.22 Million USD | -34460.144% |
| Clene Inc. | 32.16 Million USD | -2294.204% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -439766.783% |
| BeyondSpring Inc. | 3.99 Million USD | -19174.093% |
| Synlogic, Inc. | 17.27 Million USD | -4357.308% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -59130.769% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -2199900.0% |
| Peak Bio, Inc. | 10.72 Million USD | -7081.625% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1382.965% |
| Krystal Biotech, Inc. | 8.09 Million USD | -9413.221% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -334.989% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -10811.152% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -563614.365% |
| MannKind Corporation | 382.37 Million USD | -101.371% |
| Ikena Oncology, Inc. | 10.73 Million USD | -7070.795% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -188164.059% |
| Gossamer Bio, Inc. | 212.46 Million USD | -262.414% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -442428.736% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -8305.196% |
| Legend Biotech Corporation | 328.67 Million USD | -134.276% |
| Mural Oncology plc | 15 Million USD | -5030.255% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -1523.582% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -36549.215% |
| Champions Oncology, Inc. | 7.43 Million USD | -10263.392% |
| REGENXBIO Inc. | 89.29 Million USD | -762.359% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -89990.406% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -139145.039% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -14122.386% |
| Vaxart, Inc. | 26.51 Million USD | -2804.126% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -4817.815% |
| Cellectis S.A. | 92.85 Million USD | -729.268% |
| Longeveron Inc. | 2.04 Million USD | -37626.605% |
| Repare Therapeutics Inc. | 3.41 Million USD | -22480.645% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 44.874% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1552.644% |
| Revolution Medicines, Inc. | 87.94 Million USD | -775.557% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -444986.705% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -19378.877% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -242802.208% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -439900.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 4.75% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1373.938% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -5245.194% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -55940.757% |
| Cingulate Inc. | 3.13 Million USD | -24460.628% |
| Passage Bio, Inc. | 26.29 Million USD | -2828.425% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -11452.888% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -188625.49% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -86029.754% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -3644.954% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -61011.111% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -31314.198% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -24555.78% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -94844.513% |
| OmniAb, Inc. | 25.56 Million USD | -2912.402% |
| Anew Medical, Inc. | 1.6 Million USD | -47875.078% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -2502.858% |
| Lipocine Inc. | 17.16 Thousand USD | -4485511.092% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -6516.257% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -2123.634% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -12935.252% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1246.79% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -379210.345% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -14808.035% |
| Ocugen, Inc. | 6.94 Million USD | -10993.502% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -5349.784% |
| Q32 Bio Inc. | 1.31 Million USD | -58321.851% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -114483.333% |
| Alumis Inc. Common Stock | 32.58 Million USD | -2263.413% |
| Equillium, Inc. | 824 Thousand USD | -93346.602% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -8381.11% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -255878.937% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -405.584% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -1405.73% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -99248.686% |
| Dominari Holdings Inc. | 3.02 Million USD | -25329.326% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -814826.921% |
| vTv Therapeutics Inc. | 529 Thousand USD | -145457.656% |
| Bio-Techne Corporation | 419.53 Million USD | -83.535% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -969.504% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -297.797% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -4459.45% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -3282.831% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -12610.466% |
| Nkarta, Inc. | 88.33 Million USD | -771.642% |
| BioCardia, Inc. | 1.31 Million USD | -58455.133% |
| Iterum Therapeutics plc | 19.5 Million USD | -3846.896% |